What investigations are indicated for a 40‑year‑old man who had influenza three weeks ago and now presents with one week of acute myelitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Investigations for Acute Myelitis Following Influenza Infection

Obtain an urgent contrast-enhanced MRI of the entire spine immediately as the first-line investigation to confirm myelitis, define lesion extent, exclude surgical emergencies like epidural abscess, and guide further diagnostic workup. 1

Immediate Imaging

  • Perform whole-spine MRI with and without gadolinium contrast as the mandatory initial study, since multilevel involvement occurs in approximately 51% of spinal infections and skip lesions appear in 8% of cases 1
  • Contrast enhancement is essential to reveal characteristic infection-related patterns, abscess formation, meningeal involvement, and to differentiate infectious from autoimmune etiologies 2, 1
  • Do not delay MRI while awaiting laboratory results—timely imaging is critical to identify spinal cord compression or epidural abscess requiring emergent neurosurgical intervention 1
  • Single-level imaging is inadequate; the entire spine must be visualized to detect multifocal disease 1

Laboratory Investigations (Pre-Treatment)

Blood Tests

  • Draw two sets of blood cultures from separate sites before starting any antimicrobials to maximize pathogen recovery 1
  • Measure inflammatory markers: ESR and CRP—a CRP >100 mg/L strongly suggests active spinal infection and is more sensitive than white blood cell count 2, 1
  • Complete blood count with differential—note that up to 40% of spinal infections present with normal WBC, so a normal count does not exclude infection 1
  • Screen for HIV, diabetes mellitus, and immunosuppressive conditions as these are major risk factors for infectious myelitis 2, 1

Autoimmune Serology

  • Test for anti-aquaporin-4 (AQP4) antibodies using cell-based assay to evaluate for neuromyelitis optica spectrum disorder (NMOSD), particularly given the post-influenza timing 3, 4, 5
  • Test for anti-MOG (myelin-oligodendrocyte glycoprotein) antibodies using cell-based assay only—ELISA has poor specificity and should not be used 2, 3, 4
  • Consider testing both AQP4 and MOG antibodies in parallel if resources permit, as influenza-associated myelitis can trigger MOG-antibody positive longitudinally extensive transverse myelitis 3, 4

Cerebrospinal Fluid Analysis

  • Perform lumbar puncture unless contraindicated (raised intracranial pressure with brain shift, coagulopathy, or thrombocytopenia) 2
  • CSF studies should include:
    • Cell count with differential (neutrophilic pleocytosis or WCC >50/μL suggests MOG-EM or NMOSD rather than MS) 3
    • Protein and glucose with CSF/serum glucose ratio 2
    • Oligoclonal bands (absence in 87-88% of MOG-EM patients helps distinguish from multiple sclerosis) 3
    • Viral PCR panel including HSV-1/2, VZV, enterovirus, and influenza A/B PCR given the recent flu history 2, 6
    • Bacterial and fungal cultures 2
    • Cytology and flow cytometry 2

Additional Investigations Based on Clinical Context

If Infectious Etiology Suspected

  • Obtain serologic testing for endemic pathogens (Mycobacterium tuberculosis, Brucella, Coccidioides, Schistosoma) based on geographic exposure risk 2, 1
  • Consider image-guided biopsy if tuberculosis is suspected (large paraspinal abscess disproportionate to bone destruction) before starting anti-tubercular therapy 1

If Autoimmune/Post-Infectious Etiology Suspected

  • Antinuclear antibodies (ANA), extractable nuclear antigen (ENA), double-stranded DNA antibodies 2
  • Complement levels (C3, C4), lupus anticoagulant, cardiolipin antibodies 2
  • Antithyroid antibodies (thyroglobulin, thyroperoxidase) 2
  • Voltage-gated potassium channel complex antibodies and NMDA receptor antibodies if encephalitic features present 2

Critical Timing Considerations

  • Delay empiric antimicrobial therapy until after blood cultures and CSF are obtained unless the patient is hemodynamically unstable, septic, or has rapid neurologic decline 1
  • If empiric therapy is required immediately, initiate vancomycin (MRSA coverage) plus third- or fourth-generation cephalosporin (gram-negative coverage) and add acyclovir for HSV/VZV coverage 1
  • For post-infectious/autoimmune myelitis, high-dose intravenous methylprednisolone (1,000 mg daily for 5 days) is first-line treatment and should not be delayed once infection is excluded 3, 6

Red Flags Requiring Immediate Neurosurgical Consultation

  • New or worsening motor weakness, ascending sensory level, or bowel/bladder dysfunction 1
  • MRI evidence of epidural abscess or significant spinal cord compression 2, 1
  • Spinal instability or pronounced kyphotic deformity 1

Common Pitfalls to Avoid

  • Do not assume a normal white blood cell count excludes infection—inflammatory markers (CRP, ESR) are more reliable 1
  • Do not start antibiotics before obtaining cultures/CSF unless the patient meets instability criteria, as premature therapy markedly reduces diagnostic yield 1
  • Do not use ELISA for MOG antibody testing—only cell-based assays are acceptable 2, 3
  • Do not limit imaging to the symptomatic level—whole-spine MRI is mandatory 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.